Resonate Blends, Inc. (KOAN) stock: key figures, P/E, revenue and dividend

Information Technology · United States

Price
0.00 USD
Market cap
19,618.69 USD
P/E (2025)
–
P/S (2025)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

Resonate Blends, Inc. financials

Fiscal year2024
Revenue1.90 m USD
Gross profit1.24 m USD
Operating income-1.70 m USD
EBIT-2.13 m USD
Net income-2.13 m USD
Diluted EPS – continuing operations-0.02 USD

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Resonate Blends, Inc.

Resonate Blends, Inc. engages in the discovery, development, and marketing of products for mankind in the field of regenerative medicine. It focuses on marketing licensed patent-pending natural stem cell mobilizing agents for enhancing individual's ability to mobilize their own adult stem cells from their bone marrow. The company also has a license to market a dual acting all-natural diet aid to help control hunger through normal body signals to the brain and stomach. In addition, it is involved in the research and development activities focusing on exploring other areas, such as Secretogues to enhance a person's own growth hormone production and similar natural bioactive formulations to enhance human performance utilizing known body mechanisms without the use of drugs. The company is based in North Bergen, New Jersey.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.